Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer

Virchows Archiv

Volumn 456, Issue 3, 2010, Pages 251-260

  Hansen, Torben Frøstrup ^a   Sørensen, Flemming Brandt ^a   Spindler, Karen Lise Garm ^a   Olsen, Dorte Aalund ^a   Andersen, Rikke Fredslund ^a   Lindebjerg, Jan ^a   Brandslund, Ivan ^a   Jakobsen, Anders ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Colorectal neoplasm; Microvessel density; Single nucleotide polymorphisms; Vascular endothelial growth factor receptors

Indexed keywords

CALDESMON; CD34 ANTIBODY; CD34 ANTIGEN; ENDOGLIN; GENOMIC DNA; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CANCER TISSUE; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MICROVESSEL DENSITY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; COLORECTAL TUMOR; GENETICS; HISTOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD34; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROVESSELS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77949724737     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0878-8     Document Type: Article

References (30)

1. N Weidner JP Semple WR Welch, et al. 1991 Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 324 1 8 1:STN:280:DyaK3M%2FnsVWquw%3D%3D 1701519 (Pubitemid 24058195)
2. S Hansen DA Grabau C Rose, et al. 1998 Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density Lab Invest 78 1563 1573 1:STN:280:DyaK1M%2Fps1arsQ%3D%3D 9881956 (Pubitemid 29022232)
3. RS Saad YL Liu G Nathan, et al. 2004 Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer Mod Path 17 197 203 10.1038/modpathol.3800034 1:CAS:528:DC%2BD2cXmsVOisrg%3D (Pubitemid 41656516)
4. K Akagi Y Ikeda Y Sumiyoshi, et al. 2002 Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development Surgery 131 S109 S113 10.1067/msy.2002.119361 11821796 (Pubitemid 34118625)
5. R Minhajat D Mori F Yamasaki, et al. 2006 Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers Virchows Arch 448 127 134 10.1007/s00428-005- 0062-8 1:CAS:528:DC%2BD28XhsVartbY%3D 16177881 (Pubitemid 43237877)
6. DW Miller W Graulich B Karges, et al. 1999 Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells Int J Cancer 81 568 572 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X 1:STN:280:DyaK1M3jvF2msA%3D%3D 10225446 (Pubitemid 29203054)
7. E Fonsatti VL Del M Altomonte, et al. 2001 Endoglin: an accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies J Cell Physiol 188 1 7 10.1002/jcp.1095 1:CAS:528:DC%2BD3MXktVaisLo%3D 11382917 (Pubitemid 32476491)
8. E Fonsatti L Sigalotti P Arslan, et al. 2003 Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies Curr Cancer Drug Targets 3 427 432 10.2174/1568009033481741 1:CAS:528:DC%2BD3sXhtVSmurjO 14683500 (Pubitemid 38017479)
9. D Royston DG Jackson 2009 Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma J Pathol 217 608 619 10.1002/path.2517 1:CAS:528:DC%2BD1MXkslWnsbg%3D 19253334
10. Y Takahashi Y Kitadai CD Bucana, et al. 1995 Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer Cancer Res 55 3964 3968 1:CAS:528:DyaK2MXotV2msLg%3D 7664263
11. E Kaio S Tanaka Y Kitadai, et al. 2003 Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma Oncology 64 61 73 10.1159/000066511 1:CAS:528:DC%2BD38XptFaqur4%3D 12457033 (Pubitemid 35477956)
12. Y Yonenaga A Mori H Onodera, et al. 2003 Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients Oncology 69 159 166 10.1159/000087840 (Pubitemid 41376915)
13. R Rajaganeshan R Prasad PJ Guillou, et al. 2007 The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases Br J Cancer 96 1112 1117 10.1038/sj.bjc.6603677 1:STN:280:DC%2BD2s3gt12jsQ%3D%3D 17353920 (Pubitemid 46608318)
14. GG Des B Uzzan P Nicolas, et al. 2006 Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature Br J Cancer 94 1823 1832 10.1038/sj.bjc.6603176 (Pubitemid 43882572)
15. AA Romani AF Borghetti RP Del, et al. 2006 The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count J Surg Oncol 93 446 455 10.1002/jso.20456 16615157 (Pubitemid 44651267)
16. C Li R Gardy BK Seon, et al. 2003 Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis Br J Cancer 88 1424 1431 10.1038/sj.bjc.6600874 1:CAS:528:DC%2BD3sXktFOgurk%3D 12778073 (Pubitemid 36606427)
17. B Xiong TJ Sun HY Yuan, et al. 2003 Cyclooxygenase-2 expression and angiogenesis in colorectal cancer World J Gastroenterol 9 1237 1240 1:CAS:528:DC%2BD3sXlvVSru7w%3D 12800231 (Pubitemid 36805659)
18. J Cheng RE Slavin JA Gallagher, et al. 2004 Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases J Hepatobiliary Pancreat Surg 11 164 170 10.1007/s00534-003-0883-2 15235888 (Pubitemid 38996939)
19. T Nakasaki H Wada C Shigemori, et al. 2002 Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer Am J Hematol 69 247 254 10.1002/ajh.10061 1:CAS:528: DC%2BD38XjtFShsrw%3D 11921018 (Pubitemid 34259846)
20. JG Kim YS Chae SK Sohn, et al. 2008 Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer Clin Cancer Res 14 62 66 10.1158/1078-0432.CCR-07-1537 1:CAS:528:DC%2BD1cXoslOn 18172253 (Pubitemid 351377979)
21. BP Schneider M Radovich GW Sledge, et al. 2008 Association of polymorphisms of angiogenesis genes with breast cancer Breast Cancer Res Treat 111 157 163 10.1007/s10549-007-9755-9 1:CAS:528:DC%2BD1cXos1WnsL0%3D 17891484 (Pubitemid 352009224)
22. SB Fox RD Leek K Smith, et al. 1994 Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, estrogen receptor, and survival Breast Cancer Res Treat 29 109 116 10.1007/BF00666186 1:STN:280:DyaK2c3ovFOltA%3D%3D 7517221 (Pubitemid 24104842)
23. G Perrone B Vincenzi D Santini, et al. 2004 Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer Cancer Lett 208 227 234 10.1016/j.canlet.2003.11.032 1:CAS:528:DC%2BD2cXktVOls74%3D 15142682 (Pubitemid 38624165)
24. JX Yu L Cui QY Zhang, et al. 2006 Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis World J Gastroenterol 12 4660 4664 1:CAS:528:DC%2BD28XpslSrsrs%3D 16937436 (Pubitemid 44269724)
25. JX Yu XT Zhang YQ Liao, et al. 2003 Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance World J Gastroenterol 9 2866 2869 1:CAS:528:DC%2BD2cXmt1Crsg%3D%3D 14669355
26. BP Schneider M Wang M Radovich, et al. 2008 Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100 J Clin Oncol 26 4672 4678 10.1200/JCO.2008.16.1612 1:CAS:528:DC%2BD1cXht1KqtLfE 18824714
27. P Bossi G Viale AK Lee, et al. 1995 Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations Cancer Res 55 5049 5053 1:CAS:528:DyaK2MXptFKhsL4%3D 7585550
28. FJ Gonzalez L Vicioso M Alvarez, et al. 2007 Association between VEGF expression in tumour-associated macrophages and elevated serum VEGF levels in primary colorectal cancer patients Cancer Biomark 3 325 333 1:CAS:528: DC%2BD1cXhtVOrtL8%3D 18048970 (Pubitemid 350187033)
29. L Hlatky P Hahnfeldt J Folkman 2002 Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us J Natl Cancer Inst 94 883 893 12072542 (Pubitemid 34778087)
30. PB Vermeulen G Gasparini SB Fox, et al. 2002 Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours Eur J Cancer 38 1564 1579 10.1016/S0959-8049(02)00094-1 1:STN:280:DC%2BD38zptlyjsQ%3D%3D 12142044 (Pubitemid 34876495)